Efficacy of Antiviral Agents against the SARS-CoV-2 Omicron Subvariant BA.2 - Takashita, Emi; Kinoshita, Noriko; Yamayoshi, Seiya; Sakai-Tagawa, Yuko; Fujisaki, Seiichiro; Ito, Mutsumi; Iwatsuki-Horimoto, Kiyoko; Halfmann, Peter; Watanabe, Shinji; Maeda, Kenji; Imai, Masaki; Mitsuya, Hiroaki; et al. (The New England journal of medicine, 2022)
Keywords: Antiviral agents; Antiviral Agents - pharmacology; Antiviral Agents - therapeutic use; Coronavirus; Coronaviruses; Correspondence; COVID-19; COVID-19 - drug therapy; Disease transmission; Global Health; Humans; Infectious Disease; Infectious Disease General; Infectious diseases; Influenza; Monoclonal antibodies; Pathogenesis; Proteins; R&D; Research & development; RNA polymerase; SARS-CoV-2 - drug effects; Severe acute respiratory syndrome coronavirus 2; Spike Glycoprotein, Coronavirus; Viral Infections; Japan; India